ENDS Chinese Vapes Act of 2026
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,674 other S bills in the 119th — cohort avg 32d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2026 · third_quarter · Tobacco
HR 1798/ S 819: End Tobacco Loopholes Act; all provisions of the bill HR 3838: Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026; provisions relating to enforcement efforts regarding illicit e-cigarettes and other unauthorized tobacco products HR 6845: S.T.O.P. Illicit Vapes Act Implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act Implementation of P.L. 117-103 Consolidated Appropriations Act, 2022; provisions related to providing FDA authority to regulate products containing synthetic nicotine Discussions related to tobacco harm reduction and pathways to authorization for tobacco and nicotine products Discussions concerning proposals to ban characterizing flavors in tobacco products Discussions regarding the FDAs need to urgently implement a compliance and enforcement plan to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products Discussions concerning nicotine analogue products and FDAs regulatory authority over such products Discussions regarding federal excise taxes and the taxation of tobacco products HR 6845: S.T.O.P. Illicit Vapes Act; all provisions of the bill S 4303: ENDS Chinese Vapes Act of 2026; all provisions of the bill Discussions related to FDA Guidance on Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization HR 10068/S 5312 PROTECT Act; all provisions of the bill S 4257 Resources To Prevent Youth Vaping Act; all provisions of the bill
Read twice and referred to the Committee on Finance.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $2,890,000 · Firm income: Not reported
Government targets: Bureau of Alcohol Tobacco Firearms & Explosives, HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Tobacco
HR 1798/ S 819: End Tobacco Loopholes Act; all provisions of the bill HR 3838: Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026; provisions relating to enforcement efforts regarding illicit e-cigarettes and other unauthorized tobacco products Implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act Implementation of P.L. 117-103 Consolidated Appropriations Act, 2022; provisions related to providing FDA authority to regulate products containing synthetic nicotine Discussions related to tobacco harm reduction and pathways to authorization for tobacco and nicotine products Discussions concerning proposals to ban characterizing flavors in tobacco products Discussions regarding the FDAs need to urgently implement a compliance and enforcement plan to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products Discussions concerning nicotine analogue products and FDAs regulatory authority over such products Discussions regarding federal excise taxes and the taxation of tobacco products HR 6845: S.T.O.P. Illicit Vapes Act; all provisions of the bill S 3213: Destruction of Hazardous Imports Act; all provisions of the bill S 4303: ENDS Chinese Vapes Act of 2026; all provisions of the bill Discussions related to FDA Guidance on Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization
Client expense: $3,200,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE